Drug Eye Africa

Alerts & Recalls

ANPP recalls one batch of Isotanak ginkgo biloba oral solution over quality defect

By Drug Eye Africa Newsroom · Algeria · 15 October 2026

The Agence Nationale des Produits Pharmaceutiques (ANPP) has ordered a batch recall of Isotanak ginkgo biloba oral solution.

The affected batch is GB-O1D25, with expiry date 04/2027. The product is manufactured by SARL ISOPHARM. The recall was notified on 05/10/2026.

The authority cited a “défaut de qualité” (quality defect) as the reason for the action. The notice classifies this as a regulatory batch recall (“Rappel de lot”), with the corresponding box checked, and does not list quarantine among the current measures.

Healthcare facilities and distributors holding batch GB-O1D25 must follow the recall instructions issued by the authority. The notice does not specify whether the product should be returned, destroyed, or held pending further instruction.

Sources

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top